BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

China

Antengene continued to execute its dual-engine growth strategy

Announces two new in-house discovered assets - ATG-031, a potential first-in-class anti-CD24 monoclonal antibody, and ATG-027, a potential first-in-class...

June 18, 2021 | News

Chinese Firm Zhongchao Partners with AbbVie Inc.to provide Medical Education Services

("Zhongchao" or the "Company"), a healthcare services company offering online healthcare information, professional training and educational services, today...

June 17, 2021 | News

Harbour BioMed and Dana-Farber to Advance Novel Biotherapies for Cancer Treatment

Harbour BioMed scientists and Dana-Farber researchers will be working together to develop novel oncologic drugs, including bispecific antibodies and CAR-T ...

June 16, 2021 | News

Chinese biotech firm Vazyme to showcase full range of COVID-19 Testing Solutions at Medlab

Medlab has become a world-famous laboratory exhibition and a globally-recognized professional IVD expo with international stature. Last year alone, the eve...

June 15, 2021 | News

Verona Pharma and Nuance Pharma to Commercialize Ensifentrine in Greater China

$40 million upfront including $25 million cash and $15 million in equity in Nuance Biotech (parent company) Up to $179 million in potential clinical, regul...

June 11, 2021 | News

China Pharma to Launch Highly Purified NMN+PQQ Product

NMN is a natural compound found in the human body and is constantly being metabolized. It is also found in trace amounts in certain foods. NMN serves as a ...

June 10, 2021 | News

WuXi XDC and LCB Signed MOU for the Development and Manufacturing of Antibody-drug Conjugates

Under the partnership, LCB will have access to XDC' integrated services in mAb, linker, payload, analytical and formulation development as well as ADC drug...

June 10, 2021 | News

Hummingbird Bioscience and Novogene to expand precision medicine testing

Partnership will enhance biomarker-driven patient enrollment in clinical trials of Hummingbird Bioscience's lead program, HMBD-001 Hummingbird Bioscience,...

June 09, 2021 | News

Dingdang Health raises US$220 million in new financing round

Mr. Yang Wenlong, founder and chairman of Dingdang Health, said: "With this round of financing, Dingdang Health will press ahead with its online-to-offline...

June 08, 2021 | News

Ascletis Received China IND Approval for Chronic hepatitis B

Ascletis Pharma Inc. (HKEX: 1672) today announces that China National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND...

June 07, 2021 | News

Arctic Vision Announces the Treatment of Dry Eye Disease

iTEAR®100 is an FDA-cleared external neurostimulation device that increases acute tear production. Arctic Vision, a clinical stage biotech company foc...

June 07, 2021 | News

China headquartered DiNovA Medtech officially takes up residence in Caesarea Industry

DiNovA Medtech is not new to Israel. Its leadership team and portfolio companies have long been actively involved in Israel's industry ecosy...

June 05, 2021 | News

China NMPA Approves MicuRx's Contezolid for Treatment of Drug-Resistant Bacterial Infection

By leveraging the proprietary technology platform built for drug discovery and screening, MicuRx R&D team discovered the next-generation oxazolidinone ...

June 04, 2021 | News

Registration Open for the 4th China Medical Devices Design

In order to boost the continuous innovation and development of China's medical device industry, deepen the cooperation among the medical device i...

June 03, 2021 | News

Stay Connected